These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10354056)

  • 21. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.
    Saka B; Akakpo AS; Bassowa A; Dapam AN; Mahamadou G; Teclessou JN; Mouhari-Toure A; Laouali AY; Mensah E; Kombaté K; Pitché P
    Ann Dermatol Venereol; 2018 Dec; 145(12):773-776. PubMed ID: 30301570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemic Stevens-Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy?
    Oliveira I; Jensen-Fangel S; da Silva D; Ndumba A; Medina C; Nanadje A; Rasmussen DN; Rudolf F; Wejse C; da Silva ZJ; Sodemann M; Laursen AL
    AIDS; 2010 Mar; 24(5):783-5. PubMed ID: 20215883
    [No Abstract]   [Full Text] [Related]  

  • 23. Nevirapine-induced stevens johnson-syndrome and fulminant hepatic failure requiring liver transplantation.
    Jao J; Sturdevant M; del Rio Martin J; Schiano T; Fiel MI; Huprikar S
    Am J Transplant; 2010 Jul; 10(7):1713-6. PubMed ID: 20642694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications.
    Rotunda A; Hirsch RJ; Scheinfeld N; Weinberg JM
    Acta Derm Venereol; 2003; 83(1):1-9. PubMed ID: 12636014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stevens - Johnson syndrome due to nevirapine.
    Namayanja GK; Nankya JM; Byamugisha JK; Ssali FN; Kityo CM; Rwambuya SD; Mugerwa RD; Mmiro FA; Morrison CS; Salata RA
    Afr Health Sci; 2005 Dec; 5(4):338-40. PubMed ID: 16615847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin.
    Phan TG; Wong RC; Crotty K; Adelstein S
    Australas J Dermatol; 1999 Aug; 40(3):153-7. PubMed ID: 10439528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatal toxic epidermolysis induced by zidovudine.
    Murri R; Antinori A; Camilli G; Zannoni G; Patriarca G
    Clin Infect Dis; 1996 Sep; 23(3):640-1. PubMed ID: 8879796
    [No Abstract]   [Full Text] [Related]  

  • 29. Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.
    Carr DF; Bourgeois S; Chaponda M; Takeshita LY; Morris AP; Castro EM; Alfirevic A; Jones AR; Rigden DJ; Haldenby S; Khoo S; Lalloo DG; Heyderman RS; Dandara C; Kampira E; van Oosterhout JJ; Ssali F; Munderi P; Novelli G; Borgiani P; Nelson MR; Holden A; Deloukas P; Pirmohamed M
    J Antimicrob Chemother; 2017 Apr; 72(4):1152-1162. PubMed ID: 28062682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Oberdorfer P; Washington CH; Jittamala P
    Pediatr Infect Dis J; 2008 Jun; 27(6):572. PubMed ID: 18458648
    [No Abstract]   [Full Text] [Related]  

  • 31. Fatal outcome of nevirapine-associated toxic epidermal necrolysis.
    Leng K; Lonsdorf A; Hartmann M
    Int J STD AIDS; 2008 Sep; 19(9):642-3. PubMed ID: 18725560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.
    Borgiani P; Di Fusco D; Erba F; Marazzi MC; Mancinelli S; Novelli G; Palombi L; Ciccacci C
    Eur J Clin Pharmacol; 2014 Mar; 70(3):275-8. PubMed ID: 24322967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efavirenz replacement by immediate full-dose nevirapine is safe in HIV-1-infected patients in Cambodia.
    Laureillard D; Prak N; Fernandez M; Ngeth C; Moeung S; Riel V; Chhneang V; Song S; Quillet C; Piketty C
    HIV Med; 2008 Aug; 9(7):514-8. PubMed ID: 18554312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxic epidermal necrolysis in a pregnant, HIV-infected woman.
    Pacheco H; Araujo T; Kerdel F
    Int J Dermatol; 2002 Sep; 41(9):600-1. PubMed ID: 12358833
    [No Abstract]   [Full Text] [Related]  

  • 35. A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility.
    Ciccacci C; Rufini S; Mancinelli S; Buonomo E; Giardina E; Scarcella P; Marazzi MC; Novelli G; Palombi L; Borgiani P
    Int J Mol Sci; 2015 Mar; 16(3):5830-8. PubMed ID: 25775161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nevirapine-induced Stevens-Johnson syndrome in an HIV patient.
    Jain V; Shome D; Natarajan S
    Cornea; 2008 Apr; 27(3):366-7. PubMed ID: 18362670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nevirapine toxicity in a cohort of HIV-1-infected pregnant women.
    João EC; Calvet GA; Menezes JA; D'Ippolito MM; Cruz ML; Salgado LA; Matos HJ
    Am J Obstet Gynecol; 2006 Jan; 194(1):199-202. PubMed ID: 16389032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis.
    Stewart A; Lehloenya R; Boulle A; de Waal R; Maartens G; Cohen K
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1313-1319. PubMed ID: 27464823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exanthema in a patient infected with the human immunodeficiency virus after starting antiretroviral treatment].
    Palacios Muñoz R; Santos González J; Bosch García R; Márquez Solero M
    Rev Clin Esp; 2000 Nov; 200(11):635-6. PubMed ID: 11196597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.